RxDoctor Payments Data

Donald Behling, MD

Family Medicine · Florence, SCNPI 1437122439

Payments from drug & device makers

$14,210in general payments, 2019–2025

Across 951 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Boehringer Ingelheim$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • GSK$969
  • Pfizer$793
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,202100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk145$1,862
Boehringer Ingelheim85$1,516
AbbVie(2 entities)109$1,384
AstraZeneca67$1,117
GSK65$969
Pfizer61$793
Amgen(2 entities)37$534
Lilly USA, LLC39$466
Novartis26$421
Johnson & Johnson29$383
Merck30$344
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$337
Esperion Therapeutics, Inc.19$327
Amarin Pharma, Inc.15$225
Exact Sciences8$214
Abbott11$201
Antares Pharma, Inc.11$197
Ironwood Pharmaceuticals, Inc12$187
E.r. Squibb & Sons, L.L.C.12$176
Takeda Pharmaceuticals U.S.A., Inc.12$175
Corcept Therapeutics8$161
Bayer10$159
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$156
Daiichi Sankyo Inc.6$128
Astellas Pharma US Inc7$125
Shield Therapeutics Inc7$120
Seqirus USA Inc6$110
Biohaven Pharmaceutical Holding Company Ltd.6$108
Axsome Therapeutics, Inc.6$95
Sumitomo Pharma America, Inc.4$95
Boston Scientific5$83
Sunovion Pharmaceuticals Inc.4$81
Insulet Corporation3$76
Dexcom, Inc.4$73
Biohaven Pharmaceuticals, Inc.4$64
Teva Pharmaceuticals USA, Inc.4$56
Dynavax Technologies Corporation3$53
Nevro Corp.3$52
Sanofi Pasteur Inc.3$51
Sanofi-aventis U.S. LLC3$44
Nestle Healthcare Nutrition Inc.3$43
Xeris Pharmaceuticals, Inc.2$43
Kaleo, Inc.3$42
Phathom Pharmaceuticals, Inc.3$38
Mylan Specialty L.p.2$30
Otsuka America Pharmaceutical, Inc.2$30
Eisai Inc.2$28
Novavax Inc1$25
Scilex Pharmaceuticals Inc.1$25
Hologic Sales And Service, LLC1$21
Impel Pharmaceuticals Inc.1$18
Corium, LLC1$18
Genentech USA, Inc.1$15
Edwards Lifesciences1$15
Arbor Pharmaceuticals, Inc.1$15
Zyla Life Sciences, Inc.1$15
Halozyme Inc1$14
Cvrx, Inc.1$13
Hikma Pharmaceuticals USA1$13
Kowa Pharmaceuticals America, Inc.1$11

How this compares

$14,210 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$303,835
Medicare patients
602
Services billed
6,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide219$254,139
EliquisApixaban230$205,896
JardianceEmpagliflozin169$173,313
FarxigaDapagliflozin Propanediol115$102,286
MounjaroTirzepatide53$69,804
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$62,102
XareltoRivaroxaban50$44,885
LipitorAtorvastatin Calcium25$38,190
LinzessLinaclotide44$31,420
EntrestoSacubitril/Valsartan27$28,044
TradjentaLinagliptin24$27,585
TrulicityDulaglutide28$26,886
Breo ElliptaFluticasone/Vilanterol54$22,280
OxycontinOxycodone Hcl27$21,131
JanumetSitagliptin Phos/Metformin Hcl21$19,948

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,862$254,139219 claims
PfizerEliquis, Lipitor$793$244,086255 claims
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Synjardy Xr$1,516$223,667223 claims
AstraZenecaFarxiga, Breztri Aerosphere, Crestor, Symbicort$1,117$136,889163 claims
Lilly USA, LLCMounjaro, Trulicity, Cymbalta$466$104,46492 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$969$100,326136 claims
Johnson & JohnsonXarelto$383$44,88550 claims
MerckJanumet, Januvia$344$32,21244 claims
AbbVieLinzess$1,384$31,42044 claims
NovartisEntresto$421$28,04427 claims
BayerKerendia$159$18,33217 claims
Axsome Therapeutics, Inc.Auvelity$95$18,08718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →